1Brown TJ, McCrary M, Tyring SK. Antiviral agents: Nonantiretroviral drugs[J]. J Am Acad Dermatol, 2002, 47(4):581-599.
2Lin P, Torres G, Tyring SK. Changing paradigms in dermatology:antivirals in dermatology[J]. Clin Dermatol, 2003, 21(5): 426-446.
3De Clercq E. Antiviral drugs in current clinical use[J]. J Clin Virol, 2004, 30(2): 115-133.
4Pereira CF, Paridaen JT. Anti-HIV drug development-an overview[J]. Curr Pharm Des, 2004, 10(32): 4005-4037.
5Majewski S, Jablonska S. New treatments for cutaneous human papillomavirus infection[J]. J Eur Acad Dermatol Venereol, 2004,18(3): 262-264.
6Park KC, Han WS. Viral skin infections: diagnosis and treatment considerations[J]. Drugs, 2002, 62(3): 479-490.
7Rivera A, Tyring SK. Therapy of cutaneous human papillomavirus infections[J]. Dermatol Ther, 2004, 17(6): 441-448.
8Naesens L,De Erikq C.Recent developments in herpesvirus therapy.Herpes 2001;8(1):12-16.
9Lin WR,Lin HH,Lee SS,et al.Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster.J Microbiol Immunol Infect 2001; 34(1):138-142.
10Ljungman P,de La Camara R,Milpied N,et al.Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants.Blood 2002 ;99(8):3050-3056.
